Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Bandaram Pharma Packtech Ltd (524602)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524602 NSE: Pharmaceuticals & Drugs | Small Cap | Bandaram Pharma Pack Share Price
₹20.49 0.34 (1.69%)
As on 25-Sep'26 16:59
Bandaram Pharma Packtech Ltd (524602)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524602 NSE: Pharmaceuticals & Drugs | Small Cap | Bandaram Pharma Pack Share Price
₹20.49 0.34 (1.69%)
As on 25-Sep'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹37 Cr.
Current Price
₹20.5
52-Week Low / High
₹17 / 50
TTM EPS
₹0.3
TTM Sales
₹78.8 Cr.
Book Value per Share
₹15.3
P/E Ratio
73.50
Lower than its 3-year historical median
Industry PE
54.9
Price to Book (P/B)
1.34
Lower than its 5-year historical median
Price to Sales (P/S)
0.47
Lower than its 5-year historical median
EV/EBITDA
15.66
Higher than its 5-year historical median
Dividend Yield
0.49%
Profitability Efficiency
Return on Equity (ROE)
7.98%
Underperforms industry median
Return on Capital Employed (ROCE)
8.41%
Underperforms industry median
Return on Assets (ROA)
2.78%
Operating Profit Margin
7.6%
Net Profit Margin
2.69%
Gross Profit Margin
5.2%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
-17.59%
Operating Profit Growth (1 Year)
-
0%
Net Profit Growth (1 Year)
-
4.21%
Asset Quality
Promoter Holding
62.66%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹9 Cr.
Equity
₹18 Cr.
Face Value
₹10
All Time Low / High
₹0.18 / 63.14
Check Before You Invest
M-Cap below 100cr DeciZen not available
Is Bandaram Pharma Packtech Ltd a good quality company?
Bandaram Pharma Packtech Ltd is a quality company, based on a multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Bandaram Pharma Packtech Ltd performance compare with that of its Peers?
Revenue growth of Bandaram Pharma Packtech Ltd vs industry peers?
Bandaram Pharma Packtech Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 0%, indicating stable growth and maintaining its market share.
Promoter shareholding and pledge status of Bandaram Pharma Packtech Ltd?
Promoters hold 62.66% of the Bandaram Pharma Packtech Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Bandaram Pharma Packtech Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 24.8% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Bandaram Pharma Packtech Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 0% | 0% | 0% | 0% | 0% | 0% | -0.9% | 5.2% | 1.7% | 1.3% | - |
| Value Creation Index ⓘ | NA | NA | NA | NA | NA | NA | -1.1 | -0.6 | -0.9 | -0.9 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10.1 | 14.8 | 12.2 | 13 |
| Sales YoY Gr. | - | NA | NA | NA | NA | NA | NA | NA | 47.1% | -17.6% | - |
| Adj EPS ⓘ | -0 | 0 | -0.3 | -1.7 | -1.8 | -0.1 | -0 | 0.2 | 0.1 | 0.1 | -0.7 |
| YoY Gr. | - | NA | NA | NA | NA | NA | NA | NA | -54.2% | 9.1% | - |
| BVPS (₹) ⓘ | -0.6 | -0.6 | -6.5 | -1 | -2.7 | -3.5 | 3.5 | 3.6 | 10.2 | 10.1 | 12.5 |
| Adj Net Profit ⓘ | -0 | 0 | -0.1 | -1.1 | -1.2 | -0 | -0 | 0.2 | 0.1 | 0.1 | -1 |
| Cash Flow from Ops. ⓘ | -0 | 0 | -0.3 | -1.1 | -1 | 0 | 2.9 | -3.9 | -3.3 | -3.3 | - |
| Debt/CF from Ops. ⓘ | -44.4 | 537.4 | -1.7 | -0.7 | -1.2 | 0 | 0 | -1.1 | -0 | -1.1 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | NA | NA | -17.6% | ||||
| Adj EPS ⓘ | NA | NA | NA | 9.1% | ||||
| BVPSⓘ | NA | NA | 42.7% | -0.8% | ||||
| Share Price | 24.8% | 32.4% | -9.7% | -34.1% | ||||
Key Financial Parameters ⓘ
| Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 2.2 | -0.2 | 4.1 | 121.3 | 96.8 | 1.5 | -3 | 6.7 | 1.7 | 1.2 | -6.1 |
| Op. Profit Mgn % ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.7 | 1.1 | 0.8 | -9.5 |
| Net Profit Mgn % ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0.9 | 1.1 | -9.4 |
| Debt to Equity ⓘ | -1 | -1 | -0.4 | -1.3 | -0.7 | -0.6 | 0 | 1.4 | 0 | 0.3 | - |
| Working Cap Days ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 118 | 172 | 318 | 912 |
| Cash Conv. Cycle ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48 | 69 | 103 | 794 |
Valuation of Bandaram Pharma Pack - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'23 | Mar'24 | Mar'25 |
|---|---|---|---|
| Sales | 18.73 | 34.08 | 36.96 |
| Operating Expenses ⓘ + | 17.58 | 31.26 | 34.14 |
| Operating Profit ⓘ | 1.15 | 2.82 | 2.82 |
| Operating Profit Margin (%) | 6.2% | 8.3% | 7.6% |
| Other Income ⓘ + | 0.19 | 0.03 | 0.09 |
| Interest ⓘ | 0.43 | 0.93 | 0.99 |
| Depreciation ⓘ | 0.59 | 0.73 | 0.61 |
| Profit Before Tax ⓘ | 0.33 | 1.19 | 1.32 |
| Tax ⓘ | 0.07 | 0.24 | 0.32 |
| Profit After Tax | 0.26 | 0.95 | 0.99 |
| PAT Margin (%) | 1.4% | 2.8% | 2.7% |
| Adjusted EPS (₹) | 0.3 | 0.4 | 0.5 |
| Dividend Payout Ratio (%) | 11.70% | 23% | 22% |
| PARTICULARS | Mar'23 | Mar'24 | Mar'25 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 3.08 | 12.28 | 12.65 | ||||||||
| Debt + | 14.20 | 12.70 | 17.15 | ||||||||
| Minority Interest | 2.05 | 2.79 | 3.17 | ||||||||
| Trade Payables | 0.24 | 4.12 | 4.36 | ||||||||
| Others Liabilities ⓘ | 0.60 | 0.67 | 1.58 | ||||||||
| Total Liabilities ⓘ | 20.17 | 32.56 | 38.92 | ||||||||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 5.03 | 4.48 | 3.95 | ||||||||
| CWIP ⓘ | 0 | 0 | 0 | ||||||||
| Investments ⓘ | 0 | 1.40 | 1.40 | ||||||||
| Inventories | 2.71 | 6.47 | 8.51 | ||||||||
| Trade Receivables | 6.62 | 14.52 | 18.76 | ||||||||
| Cash Equivalents | 0.16 | 0.04 | 0.12 | ||||||||
| Others Assets ⓘ | 5.65 | 5.64 | 6.19 | ||||||||
| Total Assets ⓘ | 20.17 | 32.56 | 38.92 | ||||||||
| PARTICULARS | Mar'23 | Mar'24 | Mar'25 |
|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | -1.10 | -4.13 | -4.93 |
| Cash Flow From Investing Activity ⓘ + | -5.30 | -1.58 | -0.08 |
| Cash Flow From Financing Activity ⓘ + | 4.47 | 5.59 | 5.09 |
| Net Cash Flow ⓘ | -1.93 | -0.11 | 0.08 |
| PARTICULARS | Mar'23 | Mar'24 | Mar'25 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 8.4 | 12.36 | 7.98 | |||||||
| ROCE (%) | 4.39 | 10.04 | 8.41 | |||||||
| Asset Turnover Ratio | 0.93 | 1.29 | 1.03 | |||||||
| PAT to CFO Conversion(x) | -4.23 | -4.35 | -4.98 | |||||||
| Working Capital Days | ||||||||||
| Receivable Days | 129 | 113.20 | 164.30 | |||||||
| Inventory Days | 52.80 | 49.20 | 73.90 | |||||||
| Payable Days | 5.40 | 29.10 | 52.70 | |||||||
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Bandaram Pharma Packtech Ltd FAQs
The current trading price of Bandaram Pharma Pack on 25-Sep-2026 16:59 is ₹20.49.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 24-Sep-2026 the market cap of Bandaram Pharma Pack stood at ₹36.82 Cr
The latest P/E ratio of Bandaram Pharma Pack as of 24-Sep-2026 is 0.00.
The latest P/B ratio of Bandaram Pharma Pack as of 24-Sep-2026 is 1.63.
The 52-week high of Bandaram Pharma Pack is ₹49.70 and the 52-week low is ₹17.25.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Bandaram Pharma Pack is ₹13.19 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Bandaram Pharma Packtech Ltd is a below average quality company.
The key valuation ratios of Bandaram Pharma Packtech Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Bandaram Pharma Packtech Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Bandaram Pharma Packtech Ltd
Bandaram Pharma Packtech Limited (Formerly Known as Shiva Medicare Limited) was incorporated in India in the year 1993 having its registered office at Bangalore, India. The company has changed its main objects to manufacturing of paper products and packing materials with more focus on catering to the needs of pharma, food and beverages industry apart from undertaking logistics business.
Bandaram Pharma Packtech decided to foray into paper industry and has been successfully running the business since 2022. Due to increased activity in this line of work, the computer sales and AMC business was slowly discontinued and the company has only one line of activity, viz, processing and supply of recycled paper. The company supplies various categories of recycled paper, both imported and indigenous, to small and medium size paper mills, located mainly in the East & West Godavari Districts of Andhra Pradesh. Bandaram Pharma Packtech has firmly established itself as a reputable supplier and has entered into long term supply contracts with several manufacturers of recycled paper.
Business area of the company
The company engaged in manufacturing of paper products and packing materials with more focus on catering to the needs of pharma, food and beverages industry.
You have 45 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
